The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Poseida Therapeutics, Inc(NASDAQ:PSTX) 
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company is developing P-BCMA-101, an autologous chimeric antigen receptor T cell (CAR-T) targeting B cell maturation antigen that is in Phase II ...
Website: http://www.poseida.com
Founded: 2014
Full Time Employees: 186
CEO: Eric M. Ostertag
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Poseida Therapeutics Days Payable Outstanding ttm (DPO)
Poseida Therapeutics Days Receivable Outstanding ttm (DSO)
Poseida Therapeutics Op Cashflow Per Share ttm
Poseida Therapeutics Free Cashflow Per Share ttm
Poseida Therapeutics Cash Per Share ttm
Poseida Therapeutics P/S ratio ttm
Poseida Therapeutics (GAAP) P/E ratio ttm
Poseida Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.